ONLINE DATABASE SEARCH -
HIV-LS-380-MEMO
1.
61404 HIV-LS-380;
EMBASE-HIV-8/6/2007
The Nucleoside Analogs 4'C-Methyl Thymidine and 4'C-Ethyl Thymidine Block
DNA Synthesis by Wild-type HIV-1 RT and Excision Proficient NRTI Resistant RT
Variants
Boyer, Paul L, Julias, John G, Ambrose, Zandrea, Siddiqui, Maqbool A,
Marquez, Victor E, and Hughes, Stephen H
Journal of Molecular Biology 2007. 371(4): 873-882
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WK7-4NS2J7P-1/2/8430d4c29634638659c2c9de6c8563ef
2.
61405 HIV-LS-380;
EMBASE-HIV-8/6/2007
Cell surface expression of CCR5 and other host factors influence the
inhibition of HIV-1 infection of human lymphocytes by CCR5
ligands
Ketas, Thomas J, Kuhmann, Shawn E, Palmer, Ashley, Zurita, Juan, He,
Weijing, Ahuja, Sunil K, Klasse, Per Johan, and Moore, John
P
Virology 2007.
364(2): 281-290
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WXR-4NFXG6Y-1/2/49a805791bb2c71ec09a66770920c924
3.
61406 HIV-LS-380;
EMBASE-HIV-8/6/2007
Synthesis of novel HIV protease inhibitors (PI) with activity against
PI-resistant virus
Raghavan, Subharekha, Lu, Zhijian, Beeson, Teresa, Chapman, Kevin T,
Schleif, William A, Olsen, David B, Stahlhut, Mark, Rutkowski, Carrie A,
Gabryelski, Lori, Emini, Emilio, and Tata, James R
Bioorganic & Medicinal Chemistry Letters 2007. In Press, Accepted Manuscript:
453
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TF9-4P9SNC1-1/2/25c7783472346256565d636417d6851d
4.
61407 HIV-LS-380;
WOS-HIV-8/3/2007
Nitroimidazoles, Part 3. Synthesis and Anti-Hiv Activity of New
N-Alkyl-4-Nitroimidazoles Bearing Benzothiazole and Benzoxazole
Backbones
Al-Soud, Y. et al.
Zeitschrift Fur Naturforschung Section B-a Journal of Chemical Sciences
2007. 62(4):
523-528
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247015500006
5.
61408 HIV-LS-380;
EMBASE-HIV-8/6/2007
In vitro fidelity of the prototype primate foamy virus (PFV) RT compared
to HIV-1 RT
Boyer, Paul L, Stenbak, Carolyn R, Hoberman, David, Linial, Maxine L, and
Hughes, Stephen H
Virology 2007. In
Press, Corrected Proof: 353
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WXR-4P5RVR0-2/2/128d900378297cc67a93a1684388a15f
6.
61409 HIV-LS-380;
EMBASE-HIV-8/6/2007
Quantitative structure activity relationship study on EC50 of anti-HIV
drugs
Hongzong, Si, Shuping, Yuan, Kejun, Zhang, Aiping, Fu, Yun-Bo, Duan, and
Zhide, Hu
Chemometrics and Intelligent Laboratory Systems 2007. In Press, Accepted Manuscript:
353
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TFP-4P4NPBY-1/2/1df63d4bd3ed6dac5d3eaa1ccb30d478
7.
61410 HIV-LS-380;
EMBASE-HIV-8/6/2007
Theoretical study on the HIV-1 integrase inhibitor
1-(5-chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl)-propenone
(5CITEP)
Nunthaboot, Nadtanet, Pianwanit, Somsak, Parasuk, Vudhichai, Kokpol,
Sirirat, and Wolschann, Peter
Journal of Molecular Structure 2007. In Press, Accepted Manuscript:
88
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6TGS-4P429HN-1/2/e72a255d79a105d045fa4a86c58c58b0
8.
61411 HIV-LS-380;
EMBASE-HIV-8/6/2007
Recombination favors the evolution of drug resistance in HIV-1 during
antiretroviral therapy
Carvajal-Rodriguez, Antonio, Crandall, Keith A, and Posada,
David
Infection, Genetics and Evolution 2007. 7(4): 476-483
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://www.sciencedirect.com/science/article/B6W8B-4N1T1T5-1/2/4bb90b208a85728074792990e0108ed4
9.
61412 HIV-LS-380;
WOS-HIV-8/3/2007
A New Cadinane Sesquiterpene With Significant Anti-Hiv-1 Activity From
the Cultures of the Basidiomycete Tyromyces Chioneus
Liu, D. et al.
Journal of Antibiotics 2007.
60(5): 332-334
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247117400007
10.
61413 HIV-LS-380;
WOS-HIV-8/3/2007
Synthesis and Pharmacological Activity of Urea and Thiourea Derivatives
of 4-Azatricyclo[5.2.2.0(2,6)] Undec-8-Ene-3,5-Dione
Struga, M. et al.
Chemical & Pharmaceutical Bulletin 2007. 55(5): 796-799
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247078000016
11.
61414 HIV-LS-380;
WOS-HIV-8/3/2007
Qsar Analysis of 5,6-Dihydro-4-Hydroxy-2-Pyrone Analogues: Hiv-1 Protease
Inhibitor
Jaiswal, M. et al.
Asian Journal of Chemistry 2007. 19(5): 4110-4112
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000246955400117
12.
61415 HIV-LS-380;
PUBMED-HIV-8/6/2007
Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for
anti-HIV microbicide
Emau, P, Tian, B, O'keefe, BR, Mori, T, McMahon, JB, Palmer, KE, Jiang,
Y, Bekele, G, and Tsai, CC
J Med Primatol
2007. 36(4-5):
244-53
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
61416 HIV-LS-380;
PUBMED-HIV-8/6/2007
Three-year immune reconstitution in PI-sparing and PI-containing
antiretroviral regimens in advanced HIV-1 disease
Samri, A, Goodall, R, Burton, C, Imami, N, Pantaleo, G, Kelleher, A,
Poli, G, Gotch, F, and Autran, B
Antivir Ther 2007.
12(4): 553-8
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
61417 HIV-LS-380;
PUBMED-HIV-8/6/2007
Some HIV antiretrovirals increase oxidative stress and alter chemokine,
cytokine or adiponectin production in human adipocytes and
macrophages
Lagathu, C, Eustace, B, Prot, M, Frantz, D, Gu, Y, Bastard, JP, Maachi,
M, Azoulay, S, Briggs, M, Caron, M, and Capeau, J
Antivir Ther 2007.
12(4): 489-500
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
61418 HIV-LS-380;
PUBMED-HIV-8/6/2007
Synthesis, Biological Activity, and Crystal Structure of Potent
Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase That Retain Activity
against Mutant Forms of the Enzyme
Morningstar, ML, Roth, T, Farnsworth, DW, Smith, MK, Watson, K, Buckheit,
RW Jr, Das, K, Zhang, W, Arnold, E, Julias, JG, Hughes, SH, and Michejda,
CJ
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
16.
61419 HIV-LS-380;
PUBMED-HIV-8/6/2007
Systematic evaluation of allele-specific real-time PCR for the detection
of minor HIV-1 variants with pol and env resistance mutations
Paredes, R, Marconi, VC, Campbell, TB, and Kuritzkes,
DR
J Virol Methods 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
17.
61420 HIV-LS-380;
PUBMED-HIV-8/6/2007
Immunomodulatory effects of two HIV protease inhibitors, Saquinavir and
Ritonavir, on lymphocytes from healthy seronegative individuals
Delmonte, OM, Bertolotto, G, Ricotti, E, and Tovo,
PA
Immunol Lett 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
18.
61421 HIV-LS-380;
PUBMED-HIV-8/6/2007
Identification and Characterization of UK-201844, A Novel Inhibitor That
Interferes with HIV-1 gp160 Processing
Blair, WS, Cao, J, Jackson, L, Jimenez, J, Peng, Q, Wu, H, Isaacson, J,
Butler, S, Chu, A, Graham, J, Malfait, AM, Tortorella, M, and Patick,
AK
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
19.
61422 HIV-LS-380;
PUBMED-HIV-8/6/2007
EVALUATION OF
HEXADECYLOXYPROPYL-9-R-[2-(PHOSPHONOMETHOXY)PROPYL]-ADENINE, CMX157, AS A
POTENTIAL TREATMENT OF HIV-1 AND HEPATITIS B VIRUS INFECTIONS
Painter, GR, Almond, MR, Trost, LC, Lampert, BM, Neyts, J, De, Clercq E,
Korba, BE, Aldern, KA, Beadle, JR, and Hostetler, KY
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
20.
61423 HIV-LS-380;
PUBMED-HIV-8/6/2007
The antimicrobial peptide LL-37 inhibits HIV-1
replication
Bergman, P, Walter-Jallow, L, Broliden, K, Agerberth, B, and Soderlund,
J
Curr HIV Res 2007.
5(4): 410-5
View Data on the NIAID Therapeutics Website
HYPERLINK:
21.
61424 HIV-LS-380;
PUBMED-HIV-8/6/2007
DDB1 and Cul4A are required for HIV-1 Vpr-induced G2
arrest
Tan, L, Ehrlich, E, and Yu, XF
J Virol 2007.